BioAdaptives (OTC: BDPT) a developer of science-driven wellness products, announced it has completed commercial manufacturing and logistics supply chain readiness, positioning the company to begin rolling out its next-generation wellness platforms next month. The company said it spent the past quarter securing standardized raw materials and partnering with GMP-compliant manufacturing facilities to support anticipated demand for its MyndSystem(TM) cognitive performance platform and upcoming Xcellara(TM) cellular wellness products.

BioAdaptives (OTC: BDPT) said its dual-platform strategy targets growing global wellness markets through the stimulant-free, WADA-compliant MyndSystem(TM), designed to support cognitive performance during the day and neurological recovery overnight, and the Xcellara(TM) platform, which is intended to support natural stem cell mobilization and is backed by human, double-blind, placebo-controlled clinical data cited by the company. BioAdaptives plans to release additional product specifications, launch timelines and scientific dossiers in the coming weeks.

To view the full press release, visit https://ibn.fm/hCUK7

About BioAdaptives Inc.

BioAdaptives, Inc. (OTC: BDPT) is a wellness and biotechnology company that develops and markets scientifically formulated, natural products that promote human and animal wellness. The company’s formulations are grounded in published and clinical research involving nutrition, stem cell biology, adaptogens, cellular transport mechanisms, and cellular health, with a focus on developing high-bioavailability health solutions that support normal physiological function.

For more information, please visit our website at www.bioadaptives.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN

This contant was orignally distributed by InvestorBrandNetwork (IBN). Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is InvestorNewsBreaks – BioAdaptives, Inc. (OTC: BDPT) Completes Manufacturing Readiness for Wellness Product Launch.